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Items for this week’s EPI Update include: 
  
• CDC Health Advisory: Influenza Antiviral Use for Persons at High 
Risk for Influenza Complications or Who Have Severe Influenza 
Illness  
  
This CDC Health Advisory is intended to re-emphasize the importance of 
considering antiviral medications for use in the treatment or prevention of 
influenza. The antiviral medications recommended for treatment or prevention of 
influenza includes oseltamivir or zanamivir. Because high levels of resistance to 
adamantine antiviral medications (rimantadine and amantadine) continue to be 
observed among circulating influenza A viruses, adamantanes are not 
recommended for treatment or prevention of influenza. 
Recommendations:  
Neuraminidase inhibitor medications (oseltamivir and zanamivir) are 
recommended for the treatment and chemoprophylaxis of influenza. Antiviral 
treatment should begin within 48 hours of symptom onset if possible, but 
treatment should still be considered for persons who present more than 48 hours 
after illness onset if they have severe influenza illness or are at higher risk for 
severe complications from influenza. Oseltamivir is approved for treatment and 
prevention of influenza for persons 1 year and older, while zanamivir is approved 
for treatment of persons 7 years and older and prevention of influenza in persons 
5 years and older.  
In some communities, circulating influenza virus strains during this influenza 
season are antigenically different from those contained in current influenza 
vaccines. Preliminary results suggest that currently available influenza vaccines 
provide some protection against influenza virus infection. Health care providers 
should contact their local public health department for assistance when an 
outbreak of influenza in an institutional setting (e.g., a long-term care facility) 
occurs.  
To reduce the burden of influenza in the U.S., CDC continues to recommend a 
three-pronged approach: influenza vaccination, use of neuraminidase inhibitor 
antiviral medications when indicated for treatment or prevention, and use of other 
measures to decrease the spread of influenza, including promotion of hand 
hygiene, respiratory hygiene, cough etiquette, and staying home from work and 
school when ill.  
For more information, please see the CDC website: 
http://www.cdc.gov/flu/professionals/antivirals/  
  
Have a healthy and happy week!  
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